Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-018708

Director acquired 6,820 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2024-06-12 Grant or award +6,820 70,159 D
Derivatives
ASELAGE STEVE Director 2024-06-12 Grant or award · Automatic Stock Option Grant +49,933 49,933 D
Loading xslF345X05/form4.xml…